 |
Martin-Luther-Universität Halle-Wittenberg | |||
| Forschungsbericht | Berichtszeitraum: | 01.01.99 - 31.12.00 | ||
| |||||||||
|
Herausgeberschaften 1999 : |
|
0 |
|
|
1 |
|
|
|
|
|
|
Monographien 1999 : |
|
0 |
|
Monographien 2000 : |
|
0 |
|
|
|
|
|
Buchbeiträge 1999 : |
|
0 |
|
|
5 |
|
|
|
|
|
|
|
15 |
|
|
|
25 |
|
|
|
|
|
|
Artikel in Konferenzbänden 1999 : |
|
0 |
|
Artikel in Konferenzbänden 2000 : |
|
0 |
|
|
|
|
Kehlen, A., Langner, J., Riemann, D.:
Transforming
growth-factor-b increases the expression of aminopeptidase N/CD13 mRNA and protein in
monocytes and monocytic cell lines.
Adv.
Exp. Med. Biol.
477 (2000) 49-56
Riemann, D., Roentsch, J., Hause, B., Langner, J.,
Kehlen, A.:
Cell-cell
contact between lymphocytes and fibroblast-like synoviocytes induces
lymphocytic expression of aminopeptidase N/CD13 and results in lymphocytic
activation.
Adv.
Exp. Med. Biol.
477 (2000) 57-66
Navarrete Santos, A., Langner, J., Riemann, D.:
Enzymatic
activity is not a precondition for the intracellular calcium increase mediated
by mAbs specific for aminopeptidase N/CD13.
Adv.
Exp. Med. Biol.
477 (2000) 43-47
Lendeckel, U., Kähne, T., Riemann, D.,
Neubert, K., Arndt, M., Reinhold, D.:
Review:
The role of membrane peptidases in immune functions.
Adv.
Exp. Med. Biol. 477 (2000) 1-24
Bank, U., Krüger S ., Langner, J., Roessner, A.:
Review: Peptidases and peptidase inhibitors in the pathogenesis of
diseases.
Adv. Exp. Med. Biol. 477 (2000) 349-378
Riemann, D., Kehlen, A., Langner, J.:
CD13 - not just a marker in leukemia typing.
Immunol.
Today 20 (1999), 83-88
Kehlen, A., Thiele, K., Riemann, D., Rainov, N., Langner, J.:
Interleukin-17 stimulates the expression of IkB-a
mRNA and the secretion of IL-6 and IL-8 in glioblastoma cell lines.
J.
Neuroimmunol. 101 (1999) 1-6
Reichert S., Riemann, D., Plaschka, B., Machulla,
H.K.:
Early-onset
periodontitis in patients with Ehlers-Danlos syndrome type III.
Quintessence
Int. 30 (1999) 785-790
Markwardt, F., Klapperstück, M., Löhn, M., Riemann,
D., Büttner, C., Schmalzing, G.:
Purinreceptors
in human B-lymphocytes.
Prog. Brain Res. 120 (1999) 345-353
Biewald,
J., Brömme, H.-J., Nilius, R., Langner, J.:
Effects of twelve months ethanol feeding on rat liver metabolic activity.
Intern. J. Mol. Med. 3 (1999) 279-284
Langner,
J., Thiem, M., Böhning V.: Comparative determination of
the antiproteolytic potential of therapeutically used protein preparations.
Intern.
J. Mol. Med. 4 (1999) 605-610
Lang H., Machulla H., Müller C.-H., Müller
C., Ottinger H., Schröder S., Schulze-Rath R., Winterhager J., Goldmann S.
(Kommission für Knochenmarktransplantation)
Empfehlungen der Deutschen Gesellschaft für
Immungenetik (DGI) für die Spenden von Knochenmark- und peripheren
hämatopoetischer Stammzellen freiwilliger nicht verwandter Spender.
DGI
Aktuell (1999) 1-14, Sonderausgabe
Dorak M.T., Lawson T., Machulla H.K.G., Mills
K.I., Darke., Burnett A.K.
Contribution
of the HLA-DRB4 locus to childhood leukemia susceptibility is male-specific.
Blood 94 (1999) 1-8
Kehlen, A., Thiele, K., Navarrete Santos, A., Langner, J., Riemann, D. Cell-cell contact of lymphocytes increases mRNA expression of
aminopeptidase N/CD13, IL-8, IkBa and phosphorylation of ERK1/2, Akt and CREB.
Eur. J. Cell Biol. 78(Suppl.49) (1999) 38
Neuhaus, K., Müller-Werdan, U., Riemann, D., Lautenschläger, C.,
Ziegler-Heitbrock, H.W.L., Zerkowski, H.R., Langner J., Werdan, K. Impact
of cardiopulmonary-bypass assisted surgery on markers of monocyte
function.
Crit Care 3 (Suppl 1) (1999) P112.
Machulla H.K.G., Stepanowa A., Langner
J., Taube K.-M.
HLA-A, B, C, DRB1, 3/4/5, DQB1 in psoriasis patients sharing atopic
dermatitis.
Human Immunol. 60, Suppl.1 (1999) p.53
Müller L., Schaaf A., Kujat
G., Kunze G., Langner J., Machulla H.K.G.
Gender and HLA in German patients with chronic lymphocytic leukemia.
Human Immunol. 60, Suppl.1 (1999) p.62
Machulla H.K.G., Müller L.,
Schaaf A., Kujat G., Kunze G., Langner J.
HLA type and onset age in patients with chronic lymphocytic leukemia.
Human Immunol. 60, Suppl.1 (1999) p.63
Machulla H.K.G., Schaaf A.,
Steinborn F., Krüger J., Rainov N.G.
HLA-A, B, C, DRB1, DRB3/4/5, DQB1 in glioma patients.
Human Immunol. 60, Suppl.2 (1999) p.83
Dorak M.T., Machulla H.K.G., Darke C.,
Poynton C.H., Barrett-Lee P., Burnett A.K.
The
overall homozygosity rate for HLA class II supertypes is increased in
malignancies.
Abstracts 25th Annual ASHI Meeting
(New Orleans/USA, October 20-24, 1999) #5.2
Human Immunol. 60, Suppl.2 (1999) p.13
Ansorge, S., Langner, J., Bühling, F., Lendeckel, U.: Proteolytic signals from Magdeburg
Immunol. Today 21 (2000) 166-167
Kehlen, A., Olsen, J., Langner, J., Riemann, D.:
Increased
lymphocytic aminopeptidase N/CD13 promoter activity after cell-cell contact.
J.
Cell. Biochem. 80 (2000) 115-123
Thiele, K., Riemann, D., Navarrete Santos, A.,
Langner, J., Kehlen, A.:
Cell-cell contact of human T cells with
fibroblasts changes lymphocytic mRNA expression: Increased mRNA expression of
interleukin-17 and interleukin-17 receptor.
Eur. Cytokine Netw.11 (2000) 53-58
Navarrete Santos, A, Langner, J., Herrmann, M., Riemann, D.:
Aminopeptidase N/CD13 is directly linked to
signal transduction pathways in monocytes.
Cell. Immunol. 200 (2000)
22-32
Navarrete Santos, A., Roentsch, J., Danielsen, E. M., Langner,
J., Riemann, D.:
Aminopeptidase
N/CD13 is associated with raft membrane microdomains in monocytes.
Biochem.
Biophys. Res. Comm. 269 (2000) 143-148
Taubert, H., Thamm, B., Meye, A., Bartel, F., Rost,
A.-K., Heidenreich, D., John, V., Brandt, J., Bache, M., Würl, P., Schmidt, H.,
Riemann, D.:
The
p53 status in juvenile chronic arthritis and rheumatoid arthritis.
Clin.
Exp. Immunol. 122 (2000) 264-269
Rainov, N.G., Krann, C.M.,
Banning, U., Riemann, D., Holzhausen, H.-J., Heidecke, V., Burger, K.J.,
Burkert, W., Körholz, D.:
Immune response induced by retrovirus-mediated HSV-tk/GCV pharmacogene
therapy in patients with glioblastoma multiforme.
Gene
Therapy 7 (2000) 1853-1858
Reichert S., Stein J., Gautsch A., Kloß
C., Krüger J., Schaaf A., Langner J., Machulla
H.K.G.
HLA-A, B, Cw, DQ-Merkmale in einer Gruppe deutscher
Patienten mit rapid progressiver Parodontitis (RPP).
Dtsch
Zahnärztl Z55 (2000) 502-507
Machulla
H.K.G., Schaaf A.
Is
there any necessity to replace the CDC screening technique by ELISA?
In:
Visuals of the 1st European Clinical
Histocompatibility Workshop (Stresa Invitational 2000, ed. Terasaki P. I.), p. 51-52
Machulla H.K.G., Schönermarck U., Schaaf A., Müller
L.P., Kloß C., Krüger J., Kunze G., Schönermarck G., Langner
J.
HLA-A,B,Cw
and DRB1, DRB3/4/5, DQB1, DPB1 frequencies in German IgA deficient individuals.
Scand. J. Immunol. 52 (2000) 207-211
Machulla
H.K.G., Müller L.P., Schaaf A., Kujat
G., Schönermarck U., Langner J.
Association
of chronic lymphocytic leukaemia with specific alleles of the HLA-DR4:DR53:DQ8
haplotype in German patients
Int. J. Cancer (2000) (accepted 2000-11-02. #
3089R)
Kehlen, A., Lauterbach, R., Kabisch, U., Navarrete Santos, A., Riemann,
D., Langner, J. Downregulation by the cytokines IL-1 and IL-4
of autotaxin expression fibroblast-like synoviocytes of patients with
rheumatoid arthritis.
Eur. J. Cell. Biol. 79 (S50) (2000) 28.
Thiele, K., Wiese, C., Riemann D., Rainov, N., Langner,
J Kehlen, A. Interleukin-17 effects and interleukin-17 receptor expression
in glioblastoma cell lines.
Eur. J. Cell. Biol. 79 (S50) (2000) 69
Navarrete
Santos, A, Langner, J., Riemann, D. Localization of aminopeptidase
N/CD13 in the triton-insoluble fraction of monocytes.
Eur. J. Cell. Biol. 79 (S50)
(2000) 59.
Meye,
A., Taubert, H., Hinze, R., Bilkenroth, U., Göhring, B., Riemann, D.,
Heynemann, H.:
Somatic VHL but not p53 mutations in sporadic
clear cell renal cell carcinoma.
Eur. Urol. 37 (Suppl.2) (2000) 130
Kehlen, A., Thiele, K., Riemann D., Langner, J. Expression and signaling of interleukin-17 receptor in fibroblast-like
synoviocytes of patients with rheumatoid arthritis.
Immunobiology.
203 (1-3) (2000) 140.
Machulla H.K.G., Schaaf A., Krüger
J., Langner J., Hillig F., Schabel J., Heynemann H.
HLA-A, B, C, DRB1/3/4/5, DQB1 in Renal Cell Carcinoma.
Human Immunol. 61 Suppl.1 (2000) p.78
Batnasan D., Steinborn F.,
Schaaf A., Krüger J., Machulla H.K.G.,
HLA frequencies of Khalha Mongolians.
Human Immunol. 61 Suppl.1 (2000) p.125
Reichert
S., Stein J., Gautsch A., Machulla H.K.G.
HLA in German patients with rapidly progressive
periodontitis (RPP) in comparison to resistant controls.
J. Clin. Periodontol. 27, Suppl.1 (2000) p.81
Dorak M.T., Sproul A., Machulla H.K.G.,
Burnett A.K., Ginson B.
Confirmation
of the male-specific HLA-DRB4*01 association in childhood leukemia.
Eur.
J. Immunogenet. 27 (2000) p.262
Dorak M.T., Lawson T., Machulla H.K.G.,
Burnett A.K.
Evidence for heterozygote advantage and sexual
antagonism in MHC-mediated prenatal selection.
Eur.
J. Immunogenet. 27 (2000) p.257
Dorak
M.T., Lawson T., Machulla H.K.G., Schaaf A., Darke C., Burnett
A.K.
Prenatal
heterozygote advantage concerns supertypical families of HLA-DRB haplotypes and
is male-specific.
Human Immunol. 61 (2000) p.55
Dorak M.T., Lawson T., Machulla H.K.G.,
Darke C., Burnett A.K.
The B1-allelic polymorphism of HSP70-2
correlates with the genealogy of HLA-DRB1 genes.
Human Immunol. 61 (2000) p.54
Müller L.P.,
Schaaf A., Kujat G., Langner J., Schmoll H.J., Machulla H.K.G.
HLA in
patients with chronic lymphocytic leukemia (CLL) depending on gender and age at
disease onset.
Onkologie 23, Sonderheft 7 (2000) 44
Matthews V.B., Witt C., Cheong K.,
Hollongsworth P.N., Machulla H.K.G., French M., Teranteroi D., Price P.
Regulation of IgA levels by MHC genes:
Implications in IgA Deficiency and IgA Nephropathy.
Abstracts of 24th Ann. Meeting of
the Australasian and South East Asian Tissue Typing Association.
(30. Nov.-3. Dec. 2000, Perth, Western
Australia)
Dorak M.T., Machulla H.K.G., Darke C.,
Poynton C.H., Barrett-Lee P., Burnett A.K.
The
overall homozygosity rate for HLA class II supertypes is increased in
malignancies.
Abstracts 25th Annual ASHI Meeting
(New Orleans/USA, October 20-24, 1999) #5.2
Human Immunol. 60, Suppl.2 (1999) p.13
Weitere Informationen zu Institut für Medizinische Immunologie :
Zurück zu